Dashboard/NURECA

NURECA

OVERVALUED

Nureca Limited

Others · NSE

51.8% vs fair value

52W Low

204

+33.3% from low

52W High

343

-20.7% from high

News sentiment
2 bull1 neu7 bear

Valuation Gauge

OVERVALUED-51.8% Margin of Safety
OVERVALUEDFAIRLY VALUEDUNDERVALUED

Current Price

₹272

Fair Value

₹179

Fair Value Analysis

₹179

Based on balance sheet strength analysis and earnings growth potential for Others sector companies | CAUTION: ROCE declining (latest 27.1%) — returns on capital are falling; verify this isn't a value trap. | Growth capped at 6.1% (ROE 5.3%×1.15) — historical CAGR exceeds sustainable rate or COVID period unverifiable.

Medium confidence

Balance Sheet Value

50% weight

₹225

Growth Valuation

50% weight

₹133

Price vs Market

NURECA
Nifty 50

Shareholding Pattern

Stock Health Score

C

Mixed Signals

5 / 10

Profitability

6/10

ROE of 5.3% is below the Others sector benchmark of 15%

Debt & Leverage

10/10

D/E ratio of 0.0x is well within the Others sector norm of 0.8x — strong balance sheet

Valuation vs Peers

10/10

P/E of 25.1x trades at a 37% discount to Others sector median (40x) — attractively valued

Cash Flow

1/10

Negative FCF of ₹-23 Cr — company is consuming more cash than it generates

Earnings Growth

1/10

5yr EPS CAGR of -73.4% — severe earnings decline

Dividend

4/10

No dividend — typical for growth-stage companies

Company Health Timeline

10-year financial health at a glance

FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue Growth
OPM %
Net Profit
Free Cash Flow
ROE %
ROCE %
Debt / Equity
Interest Cov.
Health Score
80
75
88
88
14
29
38
Strong
Moderate
Weak
Poor
No data

Sentiment Trend — Last 30 Days

Historical Returns

Key Ratios & Growth

FCF Yield

-4.3%

Free cash flow / market cap

Revenue Growth (YoY)

+49.8%

Year-on-year revenue change

Profit Growth (YoY)

-233.2%

Year-on-year PAT change

Operating Cash Flow

₹-19 Cr

TTM cash from operations

Key Financials

EPS (TTM)

₹10.8

P/E Ratio

25.1x

P/B Ratio

1.3x

ROE

5.4%

ROCE

0.9%

Debt / Equity

0.03x

Beta

0.66

Div Yield

FCF (Cr)

₹-23 Cr

Revenue (Cr)

₹110 Cr

EPS Growth 5Y

-73.4%

Mkt Cap (Cr)

₹273 Cr

52W High

₹343

52W Low

₹204

Book Value/Share

₹208.6

Financial History

PeriodRevenueOp ProfitOPM%PATEPS
TTM₹143 Cr₹7 Cr5.0%₹11 Cr₹10.82
2025-03-31₹110 Cr₹-8 Cr-7.0%₹1 Cr₹0.85
2024-03-31₹92 Cr₹-10 Cr-11.0%₹-2 Cr₹-1.79
2023-03-31₹111 Cr₹-15 Cr-13.0%₹-8 Cr₹-8.25
2022-03-31₹256 Cr₹56 Cr22.0%₹45 Cr₹44.96
2021-03-31₹213 Cr₹62 Cr29.0%₹46 Cr₹46.37
2020-03-31₹99 Cr₹10 Cr10.0%₹6 Cr₹6400.00
2019-03-31₹62 Cr₹9 Cr15.0%₹6 Cr₹6230.00

Compounded Growth Rates

Sales Growth

3Y+8.8%
5Y-7.7%
10Y

Profit Growth

3Y
5Y-24.9%
10Y

EPS Growth

3Y
5Y-25.3%
10Y

Peer Comparison

Others
StockPriceFair ValueMoS%P/EROESignal

AVRO INDIA LIMITED

₹10.3₹75.8+86.5%38.2UNDERVALUED

Magnum Ventures Limited

₹19.8₹119.4+83.4%-1.6%UNDERVALUED

DCM Shriram Industries Limited

₹41.7₹196.1+78.7%312.6%UNDERVALUED

Star Paper Mills Limited

₹141.5₹657.4+78.5%5.644.2%UNDERVALUED

HB Stockholdings Limited

₹60.5₹281.1+78.5%3.813.1%UNDERVALUED

Balkrishna Paper Mills Limited

₹18.7₹80.6+76.8%3.126.1%UNDERVALUED

Heads UP Ventures Limited

₹7.1₹28.8+75.3%3.9UNDERVALUED

Credo Brands Marketing Limited

₹88.5₹305.8+71.1%10.916.4%UNDERVALUED

Institutional Activity

Bulk deals, block deals, short selling & delivery volume — NSE data

Insider Trading

Community Pulse

Exchange Filings

BSE announcements · last 90 days

Loading filings…

Share this Stock

Download card · Share on WhatsApp

NURECA share card

Share on WhatsApp, Twitter, or any group — each share brings new users to Veritas Quant